| Name | Title | Contact Details |
|---|
Derma Sciences, Inc. (Derma Sciences) engages in the manufacture, marketing, and sale of three dermatological related product lines: wound care, wound closure, and specialty securement devices and skin care.
Qualis Health is a national leader in improving care delivery and patient outcomes, working with clients throughout the public and private sector to advance the quality, efficiency, and value of healthcare for millions of Americans every day. We deliver solutions to ensure that our partners transform the care they provide, with a focus on process improvement, care management, and effective use of health information technology.
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
American College Health Association is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nexera Consulting is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.